BeyondBio Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Yuseong Korea, Republic of (2013)

Organization Overview

First Clinical Trial
2018
NCT03579836
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

BeyondBio Inc.